250 related articles for article (PubMed ID: 18081896)
1. Successful use of etanercept in type I pityriasis rubra pilaris.
Seckin D; Tula E; Ergun T
Br J Dermatol; 2008 Mar; 158(3):642-4. PubMed ID: 18081896
[No Abstract] [Full Text] [Related]
2. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy.
Davis KF; Wu JJ; Murase JE; Rosenberg FR; Sorenson EP; Meshkinpour A
Arch Dermatol; 2007 Dec; 143(12):1597-9. PubMed ID: 18087024
[No Abstract] [Full Text] [Related]
3. Treatment of juvenile pityriasis rubra pilaris with etanercept.
Cox V; Lesesky EB; Garcia BD; O'Grady TC
J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S113-4. PubMed ID: 19119116
[No Abstract] [Full Text] [Related]
4. Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept.
Vasher M; Smithberger E; Lien MH; Fenske NA
J Drugs Dermatol; 2010 Jul; 9(7):844-50. PubMed ID: 20677542
[TBL] [Abstract][Full Text] [Related]
5. Etanercept-induced clinical remission of type II pityriasis rubra pilaris with rheumatoid arthritis.
Kim JH; Park MC; Kim SC
Acta Derm Venereol; 2012 Jul; 92(4):399-400. PubMed ID: 22513698
[No Abstract] [Full Text] [Related]
6. Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonists.
Vujic I; Richter L; Bartsch K; Monshi B; Rappersberger K
Eur J Dermatol; 2013; 23(6):895-6. PubMed ID: 24192269
[No Abstract] [Full Text] [Related]
7. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
Garcovich S; Di Giampetruzzi AR; Antonelli G; Garcovich A; Didona B
J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):881-4. PubMed ID: 20002243
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept.
Guedes R; Leite L
Dermatol Ther; 2011; 24(2):285-6. PubMed ID: 21410618
[TBL] [Abstract][Full Text] [Related]
9. Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
López-Ferrer A; Dalmau J; Fernández-Figueras MT; Puig L
Cutis; 2014 Mar; 93(3):E6-7. PubMed ID: 24738108
[No Abstract] [Full Text] [Related]
10. ILVEN: is it psoriasis? Debate based on successful treatment with etanercept.
Renner R; Colsman A; Sticherling M
Acta Derm Venereol; 2008; 88(6):631-2. PubMed ID: 19002357
[No Abstract] [Full Text] [Related]
11. Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab.
Ruzzetti M; Saraceno R; Carboni I; Papoutsaki M; Chimenti S
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):117-8. PubMed ID: 18181990
[No Abstract] [Full Text] [Related]
12. Treatment of resistant giant cell arteritis with etanercept.
Docken WP
Ann Rheum Dis; 2004 Apr; 63(4):469; author reply 469-70. PubMed ID: 15020354
[No Abstract] [Full Text] [Related]
13. Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept.
Henderson RL
J Drugs Dermatol; 2006; 5(10):1010-1. PubMed ID: 17373153
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of Langerhans'-cell histiocytosis with etanercept.
Henter JI; Karlén J; Calming U; Bernstrand C; Andersson U; Fadeel B
N Engl J Med; 2001 Nov; 345(21):1577-8. PubMed ID: 11794238
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
[No Abstract] [Full Text] [Related]
16. Successful treatment of pemphigus vulgaris with etanercept in four patients.
Shetty A; Marcum CB; Glass LF; Carter JD
J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
[TBL] [Abstract][Full Text] [Related]
17. Two cases of chronic atopic dermatitis treated with soluble tumor necrosis factor receptor therapy.
Rullan P; Murase J
J Drugs Dermatol; 2009 Sep; 8(9):873-6. PubMed ID: 19746681
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Refractory Type 1 Pityriasis Rubra Pilaris With Apremilast.
Molina-Figuera E; González-Cantero Á; Martínez-Lorenzo E; Sánchez-Moya AI; García-Olmedo O; Gómez-Dorado B; Schoendorff-Ortega C
J Cutan Med Surg; 2018; 22(1):104-105. PubMed ID: 29309244
[No Abstract] [Full Text] [Related]
19. The use of etanercept in the treatment of peristomal pyoderma gangrenosum.
Kim FS; Pandya AG
Clin Exp Dermatol; 2012 Jun; 37(4):442-3. PubMed ID: 22582915
[No Abstract] [Full Text] [Related]
20. Resolving granuloma annulare with etanercept.
Shupack J; Siu K
Arch Dermatol; 2006 Mar; 142(3):394-5. PubMed ID: 16549725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
